Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Nancy L. Bartlett | Researchclopedia

Back to researchers

Nancy L. Bartlett

Barnes-Jewish Hospital ORCID

932

Works

47,109

Citations

96

h-index

362

i10-index

Research Topics

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research CAR-T cell therapy research

Affiliations

Boston University1999–1999

Northwestern University1999–1999

Brigham and Women's Hospital1999–1999

Fox Chase Cancer Center2002–2002

BC Cancer Agency2012–2016

Top Works

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

Sattva S. Neelapu,Frederick L. Locke,et al.

20175,749 citations

Lung Cancer Treatments and Mutations

CNS Lymphoma Diagnosis and Treatment

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

Roland Schmitz,George W. Wright,et al.

20182,199 citations

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

Frederick L. Locke,Armin Ghobadi,et al.

20182,189 citations

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Jan A. Burger,Alessandra Tedeschi,et al.

20151,539 citations

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

Anas Younes,Ajay K. Gopal,et al.

20121,503 citations

Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas

Anas Younes,Nancy L. Bartlett,et al.

20101,343 citations

Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma

Thomas E. Witzig,Leo I. Gordon,et al.

20021,164 citations

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma

Ranjana H. Advani,Ian W. Flinn,et al.

20181,085 citations

Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study

Barbara Pro,Ranjana H. Advani,et al.

2012983 citations